BN Business News
Add your company to Business Communicator →

Business · 09/10/2026

EMA Approves Pfizer's COVID-19 Treatment for Severe Respiratory Disease

European Medicines Agency (EMA) has approved a new proposal for the use of a COVID-19 treatment, developed by pharmaceutical company Pfizer (NYSE: PFE), in patients with severe respiratory disease. The approval is based on a recent clinical trial that showed significant improvements in patient outcomes.

Source: EMA — Paediatric Investigation PlansOpen original release →